Press Release: Skila’s Simon Mason Rated Best Speaker at CBI’s Premier Bio/Pharmaceutical Forum on Integrated Opinion Leader Management Systems

Skila on Twitter

Press Release

Skila’s Simon Mason Rated Best Speaker at CBI’s Premier Bio/Pharmaceutical Forum on Integrated Opinion Leader Management Systems

Morris Plains, NJ, December 1, 2008 – Skila’s Simon Mason, Chief Operations Officer, received the highest speaker ratings at CBI’s Premier Bio/Pharmaceutical Forum on Integrated Opinion Leader Management Systems conference held in King of Prussia, PA, upon delivery of his presentation entitled “Key Tenets of Thought Leader Management.”

The debut program for CBI showcased how pharmaceutical companies can develop effective systems that capture thought leader engagement information, ensure appropriate analysis, increase transparency and improve compliance across global functional departments. The conference attendees shared with CBI that Simon Mason was the #1 speaker with a “very relevant—on-topic presentation” that provided the audience with “very valuable insights” on today’s KOL-focused initiatives; why companies continuously miss the mark when it comes to KOL management; the implications of keeping status quo; and the critical success factors necessary to make these initiatives work.

“It was a pleasure to speak to such an engaging audience at the Bio/Pharmaceutical Forum on Integrated Opinion Leaser Management Systems,” says Simon Mason, COO, Skila. “Establishing lasting and collaborative Relationships with Opinion Leaders is of critical importance for Pharmaceutical, Diagnostic, Biotech and Medical Device companies, and a great deal of resources are allocated to do so. This audience clearly understood the value and need for a sustainable, repeatable and transparent approach to the management of KOL relationships."

A copy of the presentation is available only to employees of Pharmaceutical, Diagnostic, Biotech and Medical Device companies and can be requested by sending an email to: marketing@skila.com

To find out more about the event, visit: http://www.cbinet.com/show_conference.cfm?confCode=PC08098

About Skila

Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.

Having developed strong relationships with a broad number of global pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.

BelHealth is a private healthcare investment fund. For more info, visit www.belhealth.com.

To receive more information:

Do You Skila?